Cancer research this year reshaped how scientists understood, detected, and treated the disease. Researchers figured out how viral infections could reawaken dormant cancer cells, leveraged lessons ...

Atezolizumab, combined with chemotherapy, did not improve survival in high-risk triple-negative breast cancer and had higher severe adverse events. A Swedish study found 30% of breast cancers were ...

Abenacianine, a fluorescent imaging agent, received FDA fast track status for enhancing tumor visualization during lung cancer surgery, showing safety and efficacy in phase 2 trials. Alecensa ...

From smart pill bottles that help people remember to take their meds to calls for better menopausal symptom relief for women with breast cancer to intriguing hints at what drives dormant tumor cells ...

Rising ovarian and uterine cancer rates are linked to high BMI, with disparities across sociodemographic index levels, particularly in low- and middle-SDI regions. Sarcopenia is prevalent in ...

Surgery and chemotherapy together improved survival in GIST patients with liver metastases, increasing median cancer-specific and overall survival significantly. Chemoradiation did not enhance relapse ...